Fighting off pain with resolvins.
Sommer
Claudia
C
Birklein
Frank
F
D000700:Analgesics / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D004281:Docosahexaenoic Acids / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D015118:Eicosapentaenoic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008954:Models, Biological; D015394:Molecular Structure; D010146:Pain / Q000188:drug therapy*
D000700:Analgesics; C518399:resolvin D1; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid; C499823:5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
Rheumatology (Oxford). 2007 Jul;46(7):1140-7
17478472
Neuropharmacology. 2007 Apr;52(5):1312-7
17360008
JAMA. 2001 Aug 22-29;286(8):954-9
11509060
Diabetes Care. 2010 Apr;33(4):839-41
20067958
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006320
19160277
Nat Med. 2010 May;16(5):592-7, 1p following 597
20383154
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006605
20091598
Nat Rev Immunol. 2008 May;8(5):349-61
18437155
Neurosci Lett. 2008 Jun 6;437(3):199-202
18423863
Pain. 2007 May;129(1-2):210-23
17335973
J Exp Med. 2002 Oct 21;196(8):1025-37
12391014
Allergy. 2009 Jun;64(6):840-8
19392990
Pain. 2009 Apr;142(3):177-178
19232471